ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Non-Human Primates.

    P. Alonso-Guallart,1 R. Duran-Struuck,1 J. Stern,1 S. Kofman,1 M. Danton,1 J. Zitsman,1 Y. Kato,1 E. Berglund,1 H. Sondermeijer,1 A. McMurchy,2 M. Levings,2 M. Sykes,1 A. Griesemer.1

    1Columbia Center for Translational Immunology, Columbia University, New York, NY; 2University of British Columbia, Vancouver, Canada

    Mixed hematopoietic chimerism is a promising approach to achieving transplantation tolerance. Transient mixed chimerism leads to renal allograft tolerance in about 70% of cynomolgus macaques…
  • 2017 American Transplant Congress

    Liver Transplantation Tolerance Using Outbred Mice.

    M. Morita,1 C. Miller,2 J. Fung,3 L. Lu,1,2 S. Qian.1,2

    1Immunology, Cleveland Clinic, Cleveland, OH; 2General Surgery, Cleveland Clinic, Cleveland, OH; 3University of Michigan, Chicago, MI

    Success of organ transplantation currently depends on life-time immunosuppression, resulting in severe side effects. Induction of donor specific tolerance is ideal, which actually spontaneously occurs…
  • 2017 American Transplant Congress

    Generation of Potent Monocytic Myeloid-Derived Suppressor Cells from Rhesus Macaque Bone Marrow.

    A. Thomson, A. Zahorchak, A. Perez-Gutierrez, M. Ezzelarab.

    Surgery (Transplant), University of Pittsburgh, Pittsburgh, PA

    Background: Myeloid-derived suppressor cells (MDSC) have shown promise in inhibiting allograft rejection and in promoting transplant tolerance in rodent models. We recently reported that monocytic…
  • 2017 American Transplant Congress

    High Eomesodermin Expression Correlates with Potent Human Allo-Reactive CD8+ Effector T Cells.

    A. Perez-Gutierrez, D. Metes, Y. Ono, A. Thomson, M. Ezzelarab.

    Surgery, University of Pittsburgh, Pittsburgh, PA

    BackgroundThe transcription factors Eomesodermin (Eomes) and T-bet are thought to play critical roles in CD8+ effector memory T cell development. However, the role of Eomes…
  • 2017 American Transplant Congress

    CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute Kidney Allograft Rejection.

    L. Schiffer,1 F. Wiehler,1 M. Daemmrich,2 K. Hueper,3 M. Mengel,4 A. Thorenz,1 S. von Vietinghoff,1 R. Song,1 M. Schiffer,1 F. Gueler.1

    1Nephrology, Hannover Medical School, Hannover, Germany; 2Pathology, Hannover Medical School, Hannover, Germany; 3Radiology, Hannover Medical School, Hannover, Germany; 4Laboratory Medicine & Pathology, University of Alberta, Edmonton, Canada

    The majority of kidney allograft rejections are T cell mediated (TCMR). However, it has been shown that in the presence of B-cell clusters the course…
  • 2017 American Transplant Congress

    Autotransplantation of the Left Lung for the Treatment of Recurrent Life Threatening Pulmonary Hemorrhage Related to Pulmonary Vascular Malformation: A Unique Chance to Study Ischemia/Reperfusion Injury.

    C. Falk,1 I. Tudorache,2 C. Müller,3 W. Sommer,2 K. Daemen,1 J. Keil,1 G. Hansen,3 A. Haverich,2 G. Warnecke,2 N. Schwerk.3

    1Institute of Transplant Immunology, IFB-Tx, MHH, Hannover, Germany; 2Department of Cardiothoracic Transplant and Vascular Surgery, MHH, Hannover, Germany; 3Department of Pediatric Pneumology, MHH, Hannover, Deutschland, Germany

    Background: Ischemia reperfusion injury (IRI) remains a major clinical problem in lung transplantation. Here, we report the investigation of IRI in a 17-year-old patient who…
  • 2017 American Transplant Congress

    Clinical Impact of Strength and Class of Pre transplant Donor Specific Antibody on Kidney Transplant Recipient Receiving Steroid Free Maintenance Immunosupression Regimen.

    O. Adebiyi, O. Simo, S. Hussain, D. Mishler, W. Goggins, T. Taber, A. Sharfuddin, M. Yaqub.

    Renal Transplant, Indiana University School of Medicine, Indianapolis, IN

    Background: The class and strength of pre- transplant DSA has been described as playing a role in determining future risk of acute rejection (AR) and…
  • 2017 American Transplant Congress

    Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetile Based Immunosuppression in De Novo Kidney Transplant Recipients: 2 Years Outcome.

    Y. Watarai,1 S. Narumi,1 M. Okada,1 R. Kimura,1 K. Hatazoe,1 K. Futamura,1 T. Yamamoto,1 T. Hiramitsu,1 M. Tsujita,1 N. Goto,1 T. Kobayashi.2

    1Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; 2Kidney Transplant Surgery, Aichi Medical University, Nagakute, Aichi, Japan

    Purpose: Once-daily tacrolimus extended-release formulation (TACER) has been accepted in kidney transplantation, however its optimal dosing are not well determined. We have validated the institutional…
  • 2017 American Transplant Congress

    Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.

    D. Hesselink,1 L. Andrews,2 B. de Winter,2 J. Tang,3 N. Shuker,2 R. Bouamar,2 R. van Schaik,4 B. Koch,2 T. Van Gelder.1

    1Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands; 3Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China; 4Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands

    Bodyweight-based dosing of tacrolimus (Tac) is considered standard care, even though the available evidence is thin. An increasing proportion of transplant recipients is overweight, prompting…
  • 2017 American Transplant Congress

    Integrated Magnetic-Electrochemical Exosome (iMEX) Technology to Detect Rejection in Kidney Transplant Recipients.

    J. Assaker, J. Park, S. Routray, S. Eskandari, H. Lee, J. Azzi.

    Transplantation Research Center, Harvard Medical School, Boston; Exosome Diagnostic Inc, Cambridge

    Methods for monitoring clinical rejection including increases in serum creatinine and urinary protein excretion may not reflect subclinical rejection. Similarly repeat biopsy may result in…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences